{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:19:21Z","timestamp":1760782761633},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,2,1]],"date-time":"1985-02-01T00:00:00Z","timestamp":476064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1985,2]]},"DOI":"10.1007\/bf01806008","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T00:25:36Z","timestamp":1119918336000},"page":"5-36","source":"Crossref","is-referenced-by-count":77,"title":["Epidemiology and endocrinology of benign breast disease"],"prefix":"10.1007","volume":"6","author":[{"given":"D. Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. S.","family":"Fentiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806008_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/joe.0.0410041","volume":"41","author":"JB Adams","year":"1968","unstructured":"Adams JB, Wong MSF: Paraendocrine behaviour of human breast carcinoma: In vitro transformation of steroids to physiologically active hormones. J Endocrinol 41: 41\u201352, 1968","journal-title":"J Endocrinol"},{"key":"BF01806008_CR2","first-page":"45","volume":"61","author":"F Agrimonti","year":"1982","unstructured":"Agrimonti F, Cavallo R, Friaria R, Violino PL, Borretta G, Angeli A: Immunoglobulin levels in breast cyst fluid: apparent connection with intracystic transcortin (CBG) binding activity. Boll Ist Sieroter (Milan) 61:45\u201350, 1982","journal-title":"Boll Ist Sieroter (Milan)"},{"key":"BF01806008_CR3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/1097-0142(197907)44:1<228::AID-CNCR2820440137>3.0.CO;2-0","volume":"44","author":"JC Allegra","year":"1979","unstructured":"Allegra JC, Lippman ME, Green L, Barlock A, Simon R, Thompson EB, Huff KK, Griffin W: Estrogen receptor values in patients with benign breast disease. Cancer 44:228\u2013231, 1979","journal-title":"Cancer"},{"key":"BF01806008_CR4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/030089168206800506","volume":"68","author":"A Angeli","year":"1982","unstructured":"Angeli A, Bocuzzi G, Agrimonti F, Brignardello E, Barbadoro E, Dogliotti L: Correlation between levels of dehydroepiandrosterone sulphate and prolactin in human breast cyst fluid. Tumori 68:393\u2013396, 1982","journal-title":"Tumori"},{"key":"BF01806008_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(47)92258-7","volume":"i","author":"HJB Atkins","year":"1947","unstructured":"Atkins HJB: The painful nodular breast: A plea for the term fibro-adenosis. Lancet i:253\u2013255, 1947","journal-title":"Lancet"},{"key":"BF01806008_CR6","first-page":"180","volume":"17","author":"G Bacigalupo","year":"1962","unstructured":"Bacigalupo G: Uber die Rolle der Oestrogene bei Mastopathie und Brustkrebs. Deutsch Gesund 17:180\u2013187, 1962","journal-title":"Deutsch Gesund"},{"key":"BF01806008_CR7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/BF01487755","volume":"38","author":"g Bacigalupo","year":"1960","unstructured":"Bacigalupo g, Schubert K: Untersuchungen uber die Oestrogenausscheidung im Urin bei Mastopathie. Klin Wochenschrift 38: 804\u2013805, 1960","journal-title":"Klin Wochenschrift"},{"key":"BF01806008_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2964(66)90092-2","volume":"2","author":"G Bacigalupo","year":"1966","unstructured":"Bacigalupo G, Schubert K: Some aspects of oestrogen metabolism in cases of human mammary neoplasias. Europ J Cancer 2:75\u201383, 1966","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR9","first-page":"201","volume":"17","author":"NP Bagli","year":"1980","unstructured":"Bagli NP, Shah PN, Mistry SS: The estriol quotient in fibrocystic disease, a high-risk group for breast cancer. Indian J Cancer 17:201\u2013204, 1980","journal-title":"Indian J Cancer"},{"key":"BF01806008_CR10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/1097-0142(19801015)46:8<1775::AID-CNCR2820460813>3.0.CO;2-7","volume":"46","author":"RM Bahu","year":"1980","unstructured":"Bahu RM, Mangkornkanok-Mark M, Albertson D, Fors E, Molteni A, Battifora H: Detection of alpha-lactalbumin in breast lesions and relationship to estrogen receptors and serum prolactin. Cancer 46:1775\u20131780, 1980","journal-title":"Cancer"},{"key":"BF01806008_CR11","first-page":"93","volume":"83","author":"C Balbi","year":"1978","unstructured":"Balbi C, Candido R, D'Ajello M: Tassi ematici dell'estradiolo e del'progesterone nelle mastopatie benigne. Arch Obst Ginecol 83:93\u201397, 1978","journal-title":"Arch Obst Ginecol"},{"key":"BF01806008_CR12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1097-0142(196404)17:4<438::AID-CNCR2820170405>3.0.CO;2-K","volume":"17","author":"BB Bertini","year":"1964","unstructured":"Bertini BB, Ber A: The ethnologic and endocrinological aspects of breast cancer and cystic mastopathy in Israel. Cancer 17: 438\u2013449, 1964","journal-title":"Cancer"},{"key":"BF01806008_CR13","first-page":"1","volume":"41","author":"T Billroth","year":"1880","unstructured":"Billroth T: Die Krankheiten der weiblichen Brustdrussen. Deutsche Chirurgie 41:1\u201355, 1880","journal-title":"Deutsche Chirurgie"},{"key":"BF01806008_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2008-1037023","volume":"40","author":"J Bischoff","year":"1980","unstructured":"Bischoff J, Rebhan EM, Prestele H, Becker H: Serumprolaktin und Anamnesevergleich bei Mammazysten und zystischer Mastopathie. Geburtsh Frauenheilk 40:65\u201371, 1980","journal-title":"Geburtsh Frauenheilk"},{"key":"BF01806008_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000228374","volume":"10","author":"B Bjorklund","year":"1957","unstructured":"Bjorklund B, Bjorklund V: Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique: Presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy Appl Immunol 10:153\u2013161, 1957","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"BF01806008_CR16","first-page":"388","volume":"29","author":"MM Black","year":"1972","unstructured":"Black MM, Barclay TH, Cutler ST, Hankey BF, Asire AJ: Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer 29:388\u2013343, 1972","journal-title":"Cancer"},{"key":"BF01806008_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archsurg.1921.01110090002001","volume":"3","author":"JC Bloodgood","year":"1921","unstructured":"Bloodgood JC: The pathology of chronic cystic mastitis of the female breast with special consideration of the bluedomed cyst. Arch Surg 3:445\u2013542, 1921","journal-title":"Arch Surg"},{"key":"BF01806008_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijc.2910050202","volume":"5","author":"LM Boot","year":"1970","unstructured":"Boot LM: Prolactin and mammary gland carcinogenesis. The problem of human prolactin. Int J Cancer 5:167\u2013175, 1970","journal-title":"Int J Cancer"},{"key":"BF01806008_CR19","first-page":"1399","volume":"i","author":"Boston Collaborative Group","year":"1973","unstructured":"Boston Collaborative Group: Oral contraceptives and venous thromboembolic disease, surgically-confirmed gallbladder disease and breast tumours. Lancet i:1399\u20131404, 1973","journal-title":"Lancet"},{"key":"BF01806008_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2964(73)90078-9","volume":"9","author":"AR Boyns","year":"1973","unstructured":"Boyns AR, Cole EN, Griffiths K, Roberts MM, Buchan R, Wilson RG, Forrest APM: Plasma prolactin in breast cancer. Europ J Cancer 9:99\u2013102, 1973","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR21","first-page":"105","volume":"41","author":"HL Bradlow","year":"1981","unstructured":"Bradlow HL, Rosenfeld RS, Kream J, Fleisher M, O'Connor J, Schwartz MK: Steroid hormone accumulation in human breast cyst fluid. Cancer Res 41:105\u2013107, 1981","journal-title":"Cancer Res"},{"key":"BF01806008_CR22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/jcem-49-5-778","volume":"49","author":"HL Bradlow","year":"1979","unstructured":"Bradlow HL, Schwartz MK, Fleisher M, Nisselbaum JS, Boyar R, O'Connor J, Fukushima DK: Accumulation of hormones in breast cyst fluid. J Clin Endocrinol Metab 49:778\u2013782, 1979","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(73)90393-0","volume":"i","author":"MJ Brennan","year":"1973","unstructured":"Brennan MJ, Bulbrook RD, Deshpande N, Wang DY, Hayward JL: Urinary and plasma androgens in benign breast disease. Lancet i:1076\u20131079, 1973","journal-title":"Lancet"},{"key":"BF01806008_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a113089","volume":"113","author":"LA Brinton","year":"1981","unstructured":"Brinton LA, Vessey MP, Flavel R, Yeates D: Risk factor for benign breast disease. Am J Epidemiol 113:203\u2013214, 1981","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR25","first-page":"279","volume":"26","author":"PG Brooks","year":"1981","unstructured":"Brooks PG, Gart S, Heldfond AJ, Margolin ML, Allen AS: Measuring the effect of caffeine restriction on fibrocystic breast disease. The role of graphic stress telethermometry as an objective monitor of disease. J Reprod Med 26:279\u2013282, 1981","journal-title":"J Reprod Med"},{"key":"BF01806008_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2964(72)90094-1","volume":"8","author":"B Brownsey","year":"1972","unstructured":"Brownsey B, Cameron EHD, Griffiths K, Gleave EN, Forrest APM, Campbell H: Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast disease. Europ J Cancer 8:131\u2013137, 1972","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1210\/jcem-1-1-58","volume":"1","author":"NLR Bucher","year":"1941","unstructured":"Bucher NLR, Geschickter CF: Corpus luteum studies: 2. Pregnandiol and estrogen output in the urine of patients with chronic cystic mastitis. J Clin Endocrinol Metab 1:58\u201364, 1941","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR28","first-page":"1307","volume":"127","author":"SF Buhl-Jorgensen","year":"1968","unstructured":"Buhl-Jorgensen SF, Fischerman K, Johanses H, Petersen B: Cancer risk in intraductal papilloma and papillomatosis. Surg Gynecol Obstet 127:1307\u20131312, 1968","journal-title":"Surg Gynecol Obstet"},{"key":"BF01806008_CR29","first-page":"13","volume":"4","author":"RD Bulbrook","year":"1979","unstructured":"Bulbrook RD, Wang DY: Prolactin: Aetiology of breast cancer and hormone dependence in man. Revs Endocrine-Related Cancer 4:13\u201319, 1979","journal-title":"Revs Endocrine-Related Cancer"},{"key":"BF01806008_CR30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bmj.4.5738.768","volume":"4","author":"EHD Cameron","year":"1970","unstructured":"Cameron EHD, Griffiths K, Gleave EN, Stewart HJ, Forrest APM, Campbell H: Benign and malignant breast disease in South Wales: A study of urinary steroids. Brit Med J 4:768\u2013771, 1970","journal-title":"Brit Med J"},{"key":"BF01806008_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archsurg.1934.01170180003001","volume":"28","author":"OJ Campbell","year":"1934","unstructured":"Campbell OJ: Relationship between cystic disease of the breast and carcinoma. Arch Surg 28:1001\u20131056, 1934","journal-title":"Arch Surg"},{"key":"BF01806008_CR32","volume-title":"Tumours of the Breast","author":"GL Cheatle","year":"1931","unstructured":"Cheatle GL, Cutler M: Tumours of the Breast. Arnold, London, 1931"},{"key":"BF01806008_CR33","first-page":"414","volume":"15","author":"OT Clagett","year":"1944","unstructured":"Clagett OT, Plimpton NC, Root GT: Lesions of the breast. The relationship of benign lesions to carcinoma. Surgery 15:414\u2013419, 1944","journal-title":"Surgery"},{"key":"BF01806008_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0014-2964(77)90122-0","volume":"13","author":"EN Cole","year":"1977","unstructured":"Cole EN, Sellwood RA, England PC, Griffiths K: Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. Europ J Cancer 13:597\u2013603, 1977","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a112594","volume":"108","author":"P Cole","year":"1978","unstructured":"Cole P, Elwood JM, Kaplan SD: Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol 108:112\u2013120, 1978","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0091-7435(79)90028-8","volume":"8","author":"LJ Coombs","year":"1979","unstructured":"Coombs LJ, Lilienfeld AM, Bross IDJ, Burnett W: A prospective study of the relationship between benign breast disease and breast carcinoma. Prev Med 8:40\u201352, 1979","journal-title":"Prev Med"},{"key":"BF01806008_CR37","doi-asserted-by":"crossref","unstructured":"Cooper AP: The anatomy and diseases of the breast. 1845","DOI":"10.1097\/00000441-184510000-00023"},{"key":"BF01806008_CR38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.1931.02720410011004","volume":"96","author":"M Cutler","year":"1931","unstructured":"Cutler M: The cause of \u2018painfull breasts\u2019 and treatment by means of ovarian residue. J Am Med Assoc 96:1201\u20131205, 1931","journal-title":"J Am Med Assoc"},{"key":"BF01806008_CR39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/1097-0142(196408)17:8<957::AID-CNCR2820170802>3.0.CO;2-O","volume":"17","author":"HH Davis","year":"1964","unstructured":"Davis HH, Simons MA, Davis TB: Cystic disease of the breast: relationship to carcinoma. Cancer 17:957\u2013978, 1964","journal-title":"Cancer"},{"key":"BF01806008_CR40","doi-asserted-by":"crossref","unstructured":"DeBoever J, Vanderkerckhove D: Benign breast disease: Steroid concentrations. J Steroid Biochem 17:cxiii, 1982","DOI":"10.1016\/0022-4731(82)90552-0"},{"key":"BF01806008_CR41","first-page":"185","volume":"33","author":"G DeSanso","year":"1981","unstructured":"DeSanso G, Bracco G, Tanferna M, Graffino W, Panazzolo A: Ruolo dei tumori benigni e delle displasie mammarie nella cancerogenesi in relazione alla attivitia degli enzimi lisosomiali a-arilsolfatasi e b-glucuronidasi. Minerva Ginecol 33:185\u2013196, 1981","journal-title":"Minerva Ginecol"},{"key":"BF01806008_CR42","first-page":"2","volume":"68","author":"P Delbet","year":"1893","unstructured":"Delbet P: Maladie cystique de la mammelle. Bull Soc d'Anat de Paris 68:2, 1893","journal-title":"Bull Soc d'Anat de Paris"},{"key":"BF01806008_CR43","first-page":"803","volume":"134","author":"JE Devitt","year":"1972","unstructured":"Devitt JE: Fibrocystic disease of the breast is not premalignant. Surg Gynecol Obstet 134:803\u2013806, 1972","journal-title":"Surg Gynecol Obstet"},{"key":"BF01806008_CR44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(76)91625-1","volume":"i","author":"JE Devitt","year":"1976","unstructured":"Devitt JE: Breast cancer and preceding benign breast diseases. A chance association. Lancet i:793\u2013795, 1976","journal-title":"Lancet"},{"key":"BF01806008_CR45","first-page":"69","volume":"70","author":"WG Dilley","year":"1983","unstructured":"Dilley WG, Leight GS, Silva JS, Ammirata S, Haagensen DE, Wells SA: Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma. J Nat Cancer Inst 70:69\u201374, 1983","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR46","first-page":"650","volume":"50","author":"PK Donnelly","year":"1975","unstructured":"Donnelly PK, Baker KW, Carney JA, O'Fallon WM: Benign breast lesions and subsequent breast carcinomas in Rochester Minnesota. Mayo Clin Proc 50:650\u2013656, 1975","journal-title":"Mayo Clin Proc"},{"key":"BF01806008_CR47","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(76)92761-6","volume":"i","author":"M Dowsett","year":"1976","unstructured":"Dowsett M, Gazet JC, Powles TJ, Easty GC, Neville AM: Benign breast lesions and osteolysis. Lancet i:970\u2013971, 1976","journal-title":"Lancet"},{"key":"BF01806008_CR48","first-page":"213","volume":"7","author":"PC England","year":"1981","unstructured":"England PC, Sellwood RA, Knyba RE, Irvine JDB: Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease. Clin Oncol 7:213\u2013219, 1981","journal-title":"Clin Oncol"},{"key":"BF01806008_CR49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/bjc.1974.237","volume":"30","author":"PC England","year":"1974","unstructured":"England PC, Skinner LG, Cottrell KM, Sellwood RA: Serum oestradiol-17\u03b2 in women with benign and malignant breast disease. Brit J Cancer 30:571\u2013576, 1974","journal-title":"Brit J Cancer"},{"key":"BF01806008_CR50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/bjs.1800621014","volume":"62","author":"PC England","year":"1975","unstructured":"England PC, Skinner LG, Cottrell KM, Sellwood RA: Sex hormones in breast disease. Brit J Surg 62:806\u2013809, 1975","journal-title":"Brit J Surg"},{"key":"BF01806008_CR51","first-page":"263","volume":"91","author":"VA Ernster","year":"1982","unstructured":"Ernster VA, Mason L, Goodson WH, Sickles EA, Sacks ST, Selvin S, Dupuy ME, Hawkinson J, Hunt TK: Effects of caffeine-free diet on benign breast disease. A randomized trial. Surgery 91:263\u2013267, 1982","journal-title":"Surgery"},{"key":"BF01806008_CR52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jnci\/55.4.767","volume":"55","author":"E Fasal","year":"1975","unstructured":"Fasal E, Paffenbarger RS: Oral contraceptives as related to cancer and benign lesions of the breast. J Nat Cancer Inst 55:767\u2013773, 1975","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/bjc.1971.85","volume":"25","author":"P Feherty","year":"1971","unstructured":"Feherty P, Farrer-Brown G, Kellie AE: Oestradiol receptor in carcinoma and benign disease of the breast: An in vitro assay. Brit J Cancer 25:697\u2013710, 1971","journal-title":"Brit J Cancer"},{"key":"BF01806008_CR54","first-page":"1213","volume":"22","author":"M Fleisher","year":"1976","unstructured":"Fleisher M, Breed C, Robbins G, Fracchia A, Urban J, Schwartz M: The elemental composition of human breast fluid. Clinical Chem 22:1213, 1976","journal-title":"Clinical Chem"},{"key":"BF01806008_CR55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/clinchem\/20.1.41","volume":"20","author":"M Fleisher","year":"1974","unstructured":"Fleisher M, Oettegen HF, Breed CN, Robbins GF, Pinsky CM, Schwartz MK: CEA like material in fluid from benign cysts of the breast. Clin Chem 20:41\u201342, 1974","journal-title":"Clin Chem"},{"key":"BF01806008_CR56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ijc.2910300204","volume":"30","author":"NT Fleming","year":"1982","unstructured":"Fleming NT, Armstrong BK, Sheiner HJ: The comparative epidemiology of benign breast lumps and breast cancer in Western Australia. Int J Cancer 30:147\u2013152, 1982","journal-title":"Int J Cancer"},{"key":"BF01806008_CR57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000658-194502000-00009","volume":"121","author":"FW Foote","year":"1945","unstructured":"Foote FW, Stewart FW: Comparative studies of cancerous versus noncancerous breasts. Ann Surg 121:197\u2013222, 1945","journal-title":"Ann Surg"},{"key":"BF01806008_CR58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/jcem-55-3-428","volume":"55","author":"S Fournier","year":"1982","unstructured":"Fournier S, Kuttenn F, De Cicco F, Baudot N, Malet C, Mauvais-Jarvis P: Estradiol 17\u03b2-hydroxysteroid dehydrogenase activity in human breast fibroadenomas. J Clin Endocrinol Metab 55:428\u2013433, 1982","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0009-8981(83)90348-0","volume":"131","author":"R Frairia","year":"1983","unstructured":"Frairia R, Agrimonti F, Barbadoro E, Fazzari A, Buccuzzi G, Angeli A: Evidence for a transcortin-like component in human breast cyst fluid. Clin Chim Acta 131:15\u201327, 1983","journal-title":"Clin Chim Acta"},{"key":"BF01806008_CR60","first-page":"127","volume":"37","author":"P Franchimont","year":"1976","unstructured":"Franchimont P, Dourcy C, Legros JJ, Reuter A, Vrindts-Gevaert Y, Van Cauwenberge JR, Remacle P, Gaspard U, Colin C: Dosage de la prolactine dans les conditions normales et pathologiques. Ann Endocrinol (Paris) 37:127\u2013156, 1976","journal-title":"Ann Endocrinol (Paris)"},{"key":"BF01806008_CR61","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/1097-0142(197706)39:6<2806::AID-CNCR2820390668>3.0.CO;2-3","volume":"39","author":"P Franchimont","year":"1977","unstructured":"Franchimont P, Zangerle PF, Hendrick JC, Reuter A, Colin C: Simultaneous assays of cancer associated antigens in benign and malignant breast diseases. Cancer 39:2806\u20132812, 1977","journal-title":"Cancer"},{"key":"BF01806008_CR62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.4.5940.320","volume":"4","author":"S Franks","year":"1974","unstructured":"Franks S, Ralphs DNL, Seagroatt V, Jacobs HS: Prolactin concentration in patients with breast cancer. Brit Med J 4:320\u2013321, 1974","journal-title":"Brit Med J"},{"key":"BF01806008_CR63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/1097-0142(195107)4:4<762::AID-CNCR2820040414>3.0.CO;2-V","volume":"4","author":"VK Frantz","year":"1951","unstructured":"Frantz VK, Pickren JW, Melcher GW, Auchincloss H: Incidence of chronic cystic disease in so called \u2018normal breasts\u2019. A study based on 225 postmortem examinations. Cancer 4:762\u2013783, 1951","journal-title":"Cancer"},{"key":"BF01806008_CR64","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1148\/33.6.725","volume":"33","author":"M Friedman","year":"1939","unstructured":"Friedman M, Finkler R, Antopol W: The relation of ovarian hormones to benign breast hyperplasia and neoplasia. Radiology 33:725\u2013736, 1939","journal-title":"Radiology"},{"key":"BF01806008_CR65","first-page":"58","volume":"135","author":"WW Funderburk","year":"1972","unstructured":"Funderburk WW, Rosero E, Lefall LD: Breast lesions in blacks. Surg Gynecol Obstet 135:58\u201360, 1972","journal-title":"Surg Gynecol Obstet"},{"key":"BF01806008_CR66","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/clinchem\/25.5.745","volume":"25","author":"JT Gatzy","year":"1979","unstructured":"Gatzy JT, Zaytoun MP, Gaskins K, Pearlman WH: Electrolytes of breast-cyst fluid. Clin Chem 25:745\u2013748, 1979","journal-title":"Clin Chem"},{"key":"BF01806008_CR67","first-page":"45","volume":"40","author":"S Geller","year":"1979","unstructured":"Geller S, Grenier J, Nahoul K, Scholler R: Insuffisance luteale et mastopathies benignes. Etude a la lumier des donnees de l'epreuve combinee LH-RH + TRH couplee a l'etude des steroides ovariens. Ann Endocrinol (Paris) 40:45\u201346, 1979","journal-title":"Ann Endocrinol (Paris)"},{"key":"BF01806008_CR68","first-page":"212","volume":"84","author":"RC Golinger","year":"1978","unstructured":"Golinger RC, Krebs J, Fisher ER, Danowski TS: Hormones and the pathophysiology of fibrocystic mastopathy: Elevated luteinizing hormone levels. Surgery 84:212\u2013215, 1978","journal-title":"Surgery"},{"key":"BF01806008_CR69","first-page":"648","volume":"45","author":"M Gorlich","year":"1975","unstructured":"Gorlich M, Heise E, Pradja N, Hindy I: The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas. Arch Geschwulstforsch 45:648\u2013657, 1975","journal-title":"Arch Geschwulstforsch"},{"key":"BF01806008_CR70","first-page":"19","volume":"2","author":"R Grattarola","year":"1977","unstructured":"Grattarola R: The hormonal background of breast noncancerous diseases. Senologia 2:19\u201322, 1977","journal-title":"Senologia"},{"key":"BF01806008_CR71","first-page":"3051","volume":"38","author":"R Grattarola","year":"1978","unstructured":"Grattarola R; Anovulation and increased androgenic activity at breast cancer risk in women with fibrocystic disease of the breast. Cancer Res 38:3051\u20133054, 1978","journal-title":"Cancer Res"},{"key":"BF01806008_CR72","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/1097-0142(197809)42:3+<1512::AID-CNCR2820420824>3.0.CO;2-6","volume":"42","author":"DE Haagensen","year":"1978","unstructured":"Haagensen DE, Kister SJ, Vandevoorde JP, Gates JB, Smart EK, Hansen HJ, Wells SA: Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Cancer 42:1512\u20131519, 1978","journal-title":"Cancer"},{"key":"BF01806008_CR73","volume-title":"Disease of the Breast","author":"CD Haagensen","year":"1971","unstructured":"Haagensen CD: Disease of the Breast. WB Saunders, Philadelphia, 1971"},{"key":"BF01806008_CR74","first-page":"239","volume":"62","author":"DE Haagensen","year":"1979","unstructured":"Haagensen DE, Mazoujian G, Dilley WG, Pedersen CE, Kister SJ, Wells SA: Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J Nat Cancer Inst 62:239\u2013247, 1979","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000658-197703000-00005","volume":"185","author":"DE Haagensen","year":"1977","unstructured":"Haagensen DE, Mazoujian G, Holder WD, Kister SJ, Wells SA: Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients. Ann Surg 185:279\u2013285, 1977","journal-title":"Ann Surg"},{"key":"BF01806008_CR76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0039-128X(71)90030-4","volume":"18","author":"R Hahnel","year":"1971","unstructured":"Hahnel R, Twaddle E, Vivian AB: Estrogen receptors in human breast cancer. 2. In vitro binding of estradiol by benign and malignant tumours. Steroids 18:681\u2013708, 1971","journal-title":"Steroids"},{"key":"BF01806008_CR77","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0009-8981(75)90202-8","volume":"64","author":"RA Hawkins","year":"1975","unstructured":"Hawkins RA, Hill A, Freedman B: A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta 64:203\u2013210, 1975","journal-title":"Clin Chim Acta"},{"key":"BF01806008_CR78","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/00000658-195711000-00002","volume":"146","author":"JW Hendrick","year":"1957","unstructured":"Hendrick JW: Results of treatment of carcinomas of breast; 5 to 18 years. Ann Surg 146:728\u2013750, 1957","journal-title":"Ann Surg"},{"key":"BF01806008_CR79","first-page":"741","volume":"88","author":"S Heyden","year":"1980","unstructured":"Heyden S: Coffee and fibrocystic breast disease. Surgery 88:741\u2013742, 1980","journal-title":"Surgery"},{"key":"BF01806008_CR80","first-page":"1874","volume":"30","author":"R Hilf","year":"1970","unstructured":"Hilf R, Goldenberg H, Michel I, Orlando RA, Archer FL: Enzymes, nucleic acids, and lipids in human breast cancer and normal breast tissue. Cancer Res 30:1874\u20131882, 1970","journal-title":"Cancer Res"},{"key":"BF01806008_CR81","first-page":"283","volume":"124","author":"TG Hislop","year":"1981","unstructured":"Hislop TG, Elwood JM, Risk factors for benign breast disease: A 30-year cohort study. Canadian Med Assoc J 124:283\u2013291, 1981","journal-title":"Canadian Med Assoc J"},{"key":"BF01806008_CR82","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archsurg.1959.04320100136023","volume":"79","author":"J Hodge","year":"1959","unstructured":"Hodge J, Surver J, Aponte GG: Relationship of fibrocystic disease to carcinoma of breast: study based on 876 cases. AMA Arch Surg 79:670\u2013678, 1959","journal-title":"AMA Arch Surg"},{"key":"BF01806008_CR83","first-page":"19","volume":"7","author":"J Hoff","year":"1978","unstructured":"Hoff J, Hoff-Bardier M, Bayard F: La Prolactine: Son role dans l'hormonedependance des cancers du sein. J Gyn Obst Biol Reprod 7:19\u201330, 1978","journal-title":"J Gyn Obst Biol Reprod"},{"key":"BF01806008_CR84","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/endo-98-2-438","volume":"98","author":"AJW Hsueh","year":"1976","unstructured":"Hsueh AJW, Peck EJ, Clark JH: Control of uterine oestrogen receptor level by progesterone. Endocrinology 98:438\u2013444, 1976","journal-title":"Endocrinology"},{"key":"BF01806008_CR85","first-page":"13","volume":"65","author":"WB Hutchinson","year":"1980","unstructured":"Hutchinson WB, Thomas DB, Hamlin WB, Roth GT, Peterson AV, Williams B: Risk of breast cancer in women with benign breast disease. J Nat Cancer Inst 65:13\u201320, 1980","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR86","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.1977.03270470035019","volume":"237","author":"DT Janerich","year":"1977","unstructured":"Janerich DT, Glebatis DM, Dugan JM: Benign breast disease and oral contraceptive use. J Am Med Ass 237: 2199\u20132201, 1977","journal-title":"J Am Med Ass"},{"key":"BF01806008_CR87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(72)91907-1","volume":"ii","author":"JS Jenkins","year":"1972","unstructured":"Jenkins JS, Ash S: Metabolism of testosterone by human breast tumours. Lancet ii:513\u2013514, 1972","journal-title":"Lancet"},{"key":"BF01806008_CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/pgmj.57.664.89","volume":"57","author":"MK Jones","year":"1981","unstructured":"Jones MK, Dyer GI, Ramsay ID, Collins WP: Studies on apparent free cortisol and testosterone in plasma from patients with breast tumours. Postgrad Med J 57:89\u201394, 1981","journal-title":"Postgrad Med J"},{"key":"BF01806008_CR89","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/bjc.1977.133","volume":"35","author":"MK Jones","year":"1977","unstructured":"Jones MK, Ramsay ID, Collins WP: Concentration of testosterone glucuronide in urine from women with breast tumours. Brit J Cancer 35:885\u2013887, 1977","journal-title":"Brit J Cancer"},{"key":"BF01806008_CR90","first-page":"305","volume":"5","author":"MK Jones","year":"1979","unstructured":"Jones MK, Ramsay ID, Collins WP: Plasma gonadotrophin concentrations in postmenopausal women with breast disease. Clin Oncol 5:305\u2013309, 1979","journal-title":"Clin Oncol"},{"key":"BF01806008_CR91","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/oxfordjournals.aje.a112530","volume":"107","author":"JL Kelsey","year":"1978","unstructured":"Kelsey JL, Holford TR, White C, Mayer ES, Kilty SE, Acheson RM: Oral contraceptives and breast disease. Am J Epidemiol 107:236\u2013244, 1978","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ije\/3.4.333","volume":"3","author":"JL Kelsey","year":"1974","unstructured":"Kelsey JL, Lindfors KK, White C: A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. Int J Epidemiol 3:333\u2013340, 1974","journal-title":"Int J Epidemiol"},{"key":"BF01806008_CR93","first-page":"649","volume":"96","author":"AR Kilgore","year":"1973","unstructured":"Kilgore AR, Fleming R, Ramos MM: The incidence of cancer with nipple discharge and the risk of cancer in the presence of papillary disease of the breast. Surg Gynec Obstet 96:649, 1973","journal-title":"Surg Gynec Obstet"},{"key":"BF01806008_CR94","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/1097-0142(197706)39:6<2603::AID-CNCR2820390645>3.0.CO;2-T","volume":"39","author":"D Kodlin","year":"1977","unstructured":"Kodlin D, Winger EE, Morgenstern NL, Chen V: Chronic mastopathy and breast cancer. Cancer 39:2603\u20132607, 1977","journal-title":"Cancer"},{"key":"BF01806008_CR95","first-page":"49","volume":"20","author":"F Koenig","year":"1893","unstructured":"Koenig F: Mastitis chronica cystica. Zentralbl Chir 20:49\u201353, 1893","journal-title":"Zentralbl Chir"},{"key":"BF01806008_CR96","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1172\/JCI105086","volume":"43","author":"SG Korenman","year":"1964","unstructured":"Korenman SG, Lipsett MB: Is testosterone glucuronoside uniquely derived from plasma testosterone? J Clin Invest 43:2125\u20132131, 1964","journal-title":"J Clin Invest"},{"key":"BF01806008_CR97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0039-128X(65)90120-0","volume":"5","author":"SG Korenman","year":"1965","unstructured":"Korenman SG, Lipsett MB: Direct peripheral conversion of dehydroepiandrosterone to testosterone glucuronoside. Steroids 5:509\u2013517, 1965","journal-title":"Steroids"},{"key":"BF01806008_CR98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1097-0142(197301)31:1<130::AID-CNCR2820310117>3.0.CO;2-N","volume":"31","author":"WM Kramer","year":"1973","unstructured":"Kramer WM, Rush BF: Mammary duct proliferation in the elderly. A histopathological study. Cancer 31:130\u2013137, 1973","journal-title":"Cancer"},{"key":"BF01806008_CR99","first-page":"403","volume":"62","author":"E Krompecher","year":"1916","unstructured":"Krompecher E: Zur Histogeneses und Morphologie de Cystenmamma. Beltr path Anat 62:403\u2013472, 1916","journal-title":"Beltr path Anat"},{"key":"BF01806008_CR100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/bjs.1800700516","volume":"70","author":"S Kumar","year":"1983","unstructured":"Kumar S, Mansel RE, Scanlon MF, Hughes LE: Secretory response of prolactin and TSH in benign breast disease and after TRH stimulation. Brit J Surg 70:293, 1983","journal-title":"Brit J Surg"},{"key":"BF01806008_CR101","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/jcem-52-6-1225","volume":"52","author":"F Kuttenn","year":"1981","unstructured":"Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P: Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 52:1225\u20131229, 1981","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR102","first-page":"60","volume":"2","author":"ZV Kuzmina","year":"1977","unstructured":"Kuzmina ZV, Sharoukhova KS, Muravyova NI, Goncharova MG, Molodyk AA, Vyshnyakova VV: Some features in correlations of the ovarian cycle hormones in patients with mastopathy and mammary cancer. Vestn Akad Med Nauk 2:60\u201364, 1977","journal-title":"Vestn Akad Med Nauk"},{"key":"BF01806008_CR103","first-page":"1915","volume":"71","author":"M Latteri","year":"1980","unstructured":"Latteri M, Bajardi G, Castiglione C, Caronia F, Maragliono S, Briganti A, Latteri S, Bellanca L: La prollatina nella patologia della mammella. Minerva Med 71:1915\u20131920, 1980","journal-title":"Minerva Med"},{"key":"BF01806008_CR104","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/bmj.3.5827.605","volume":"3","author":"DJR Laurence","year":"1972","unstructured":"Laurence DJR, Stevens U, Bettelheim R, Darcy D, Leese C, Turberville C, Alexander P, Johns EW, Neville AM: Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary and bronchial carcinoma. Brit Med J 3:605\u2013609, 1972","journal-title":"Brit Med J"},{"key":"BF01806008_CR105","first-page":"801","volume":"90","author":"DH Lawson","year":"1981","unstructured":"Lawson DH, Jick H, Rothman KJ: Coffee and tea consumption and breast disease. Surgery 90:801\u2013803, 1981","journal-title":"Surgery"},{"key":"BF01806008_CR106","first-page":"3","volume-title":"Hormonal Management of Endocrine-Related Cancer","author":"R Leake","year":"1981","unstructured":"Leake R: Steroid receptors in normal and cancer tissue.In Stoll BA (ed): Hormonal Management of Endocrine-Related Cancer. Lloyd-Luke Ltd, London, 1981, pp 3\u201323"},{"key":"BF01806008_CR107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/bmj.1.5951.185","volume":"1","author":"G Leclercq","year":"1975","unstructured":"Leclercq G, Heuson JC, Deboel MC, Mattheiem WH: Oestrogen receptors in breast cancer: A changing concept. Brit Med J 1:185\u2013189, 1975","journal-title":"Brit Med J"},{"key":"BF01806008_CR108","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ijc.2910220611","volume":"22","author":"AW Lees","year":"1978","unstructured":"Lees AW, Burns PE, Grace M: Oral contraceptives and breast disease in premenopausal northern Albertan women. Int J Cancer 22:700\u2013707, 1978","journal-title":"Int J Cancer"},{"key":"BF01806008_CR109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(73)90104-6","volume":"46","author":"BS Leung","year":"1973","unstructured":"Leung BS, Manaugh LC, Wood DC: Estradiol receptors in benign and malignant disease of the breast. Clin Chim Acta 46:69\u201376, 1973","journal-title":"Clin Chim Acta"},{"key":"BF01806008_CR110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM197808242990803","volume":"299","author":"VA LiVolsi","year":"1978","unstructured":"LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C: Fibrocystic breast disease in oral contraceptive users. New Engl J Med 299:381\u2013385, 1978","journal-title":"New Engl J Med"},{"key":"BF01806008_CR111","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1210\/jcem-48-4-585","volume":"48","author":"RV Lloyd","year":"1979","unstructured":"Lloyd RV: Studies on the progesterone receptor content and steroid metabolism in normal and pathological human breast tissues. J Clin Endocrinol Metab 48: 585\u2013593, 1979","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR112","first-page":"3811","volume":"41","author":"RS London","year":"1981","unstructured":"London RS, Sundaram GS, Schultz M, Nair PP, Goldstein PJ: Endocrine parameters and \u03b1-tocopherol therapy of patients with mammary dysplasia. Cancer Res 41:3811\u20133813, 1981","journal-title":"Cancer Res"},{"key":"BF01806008_CR113","first-page":"4650","volume":"37","author":"WB Malarkey","year":"1977","unstructured":"Malarkey WB, Schroeder LL, Stevens VC, James AG, Lanese RR: Disordered nocturnal prolactin regulation in women with breast cancer. Cancer Res 37:4650\u20134654, 1977","journal-title":"Cancer Res"},{"key":"BF01806008_CR114","first-page":"8","volume":"46","author":"IA Manuilova","year":"1970","unstructured":"Manuilova IA, Pshenichnikova TY: Hypophysealovarian relationships in patients with diffuse fibrocystic mastopathy. Akush Ginekol 46:8\u201311, 1970","journal-title":"Akush Ginekol"},{"key":"BF01806008_CR115","first-page":"160","volume":"8","author":"D Marchesoni","year":"1981","unstructured":"Marchesoni D, Gangemi M, Mozzanega B, Paternoster D, Graziottin A, Maggino T: Inadequate luteal phase and benign breast disease. Clin Exp Obstet Gynecol 8:160\u2013163, 1981","journal-title":"Clin Exp Obstet Gynecol"},{"key":"BF01806008_CR116","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(16)34835-9","volume":"92","author":"J Marmoston","year":"1965","unstructured":"Marmoston J, Crowley LG, Myers SM, Stern E, Hopkins CE: 2. Urinary excretion of estrone, estradiol and estriol by patients with breast cancer and benign breast disease. Am J Obstet Gynecol 92:460\u2013467, 1965","journal-title":"Am J Obstet Gynecol"},{"key":"BF01806008_CR117","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9378(16)34834-7","volume":"92","author":"J Marmoston","year":"1965","unstructured":"Marmoston J, Crowley LG, Myers SM, Stern E, Hopkins CE: I. Urinary excretion of neutral 17-ketosteroids and pregnanediol of patients with breast cancer and benign breast disease. Am J Obstet Gynecol 92:447\u2013459, 1965","journal-title":"Am J Obstet Gynecol"},{"key":"BF01806008_CR118","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0022-4731(78)90021-3","volume":"9","author":"PM Martin","year":"1978","unstructured":"Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P: Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem 9:1251\u20131255, 1978","journal-title":"J Steroid Biochem"},{"key":"BF01806008_CR119","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0022-4731(79)90198-5","volume":"11","author":"PM Martin","year":"1979","unstructured":"Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P: Progesterone receptors in breast fibroadenomas. J Steroid Biochem 11:1295\u20131298, 1979","journal-title":"J Steroid Biochem"},{"key":"BF01806008_CR120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jcem-45-5-1049","volume":"45","author":"SJ Marx","year":"1977","unstructured":"Marx SJ, Zusman RM, Umiker WO: Benign breast dysplasia causing hypercalcemia. J Clin Endocrinol Metab 45:1049\u20131052, 1977","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR121","first-page":"25","volume":"1","author":"P Mauvais-Jarvis","year":"1979","unstructured":"Mauvais-Jarvis P, Sitruk-Ware R, Kuttenn F, Sterkers N: Luteal phase insufficiency: A common pathophysiologic factor in development of benign and malignant breast diseases. Commentaries on Research in Breast Diseases 1:25\u201329, 1979","journal-title":"Commentaries on Research in Breast Diseases"},{"key":"BF01806008_CR122","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/clinchem\/22.8.1366","volume":"22","author":"CJ Menendez-Botet","year":"1976","unstructured":"Menendez-Botet CJ, Nisselbaum JS, Fleisher M, Rosen PP, Fracchia A, Robbins G, Urban JA, Schwartz MK: Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue. Clin Chem 22:1366\u20131371, 1976","journal-title":"Clin Chem"},{"key":"BF01806008_CR123","first-page":"227","volume":"9","author":"WR Miller","year":"1983","unstructured":"Miller WR, Dixon JM, Scott WN, Forrest APM: Classification of human breast cysts according to electrolyte and androgen conjugate composition. Clin Oncol 9:227\u2013232, 1983","journal-title":"Clin Oncol"},{"key":"BF01806008_CR124","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(73)91363-9","volume":"i","author":"WR Miller","year":"1973","unstructured":"Miller WR, McDonald D, Forrest APM, Shivas AA: Metabolism of androgens by human breast tissue. Lancet i:912\u2013913, 1973","journal-title":"Lancet"},{"key":"BF01806008_CR125","first-page":"1055","volume":"69","author":"WR Miller","year":"1982","unstructured":"Miller WR, Roberts MM, Creel RJ, Yap PL, Kelly RW, Forrest APM: Androgen conjugates in human breast cyst fluid. J Nat Cancer Inst 69:1055\u20131058, 1982","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR126","first-page":"299","volume":"90","author":"JP Minton","year":"1981","unstructured":"Minton JP, Abou-Issa H, Reiches N, Roseman JM: Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease. Surgery 90:299\u2013303, 1981","journal-title":"Surgery"},{"key":"BF01806008_CR127","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9378(79)80037-X","volume":"135","author":"JP Minton","year":"1979","unstructured":"Minton JP, Foecking MK, Webster DJT, Matthews RH: Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotide with breast disease. Am J Obstet Gynecol 135:157\u2013158, 1979","journal-title":"Am J Obstet Gynecol"},{"key":"BF01806008_CR128","first-page":"105","volume":"86","author":"JP Minton","year":"1979","unstructured":"Minton JP, Foecking MK, Webster DJT, Matthews RH: Caffeine cyclic nucleotides and breast disease. Surgery 86:105\u2013108, 1979","journal-title":"Surgery"},{"key":"BF01806008_CR129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/57.1.39","volume":"57","author":"JP Minton","year":"1976","unstructured":"Minton JP, Matthews RH, Wisenbaugh TW: Elevated levels of 3\u20325\u2032-cyclic monophosphate levels in human and animal tumours in vivo. J Nat Cancer Inst 57:39\u201341, 1976","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR130","first-page":"85","volume":"20","author":"E Mirabile","year":"1968","unstructured":"Mirabile E, Zanghi M, Azzolina P: Esplorazione funzionale dell'asse diencefalo-anteipofisario e degli organi endocrini periferici notoriamente correlati all'attivita della mammella femminile, in casa clinici di mastopatia fibrocistica. Chirug Italiana 20:85\u2013104, 1968","journal-title":"Chirug Italiana"},{"key":"BF01806008_CR131","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(76)91026-6","volume":"ii","author":"RR Monson","year":"1976","unstructured":"Monson RR, Yen S, Macmahon B, Warren S: Chronic mastitis and carcinoma of the breast. Lancet ii:224\u2013226, 1976","journal-title":"Lancet"},{"key":"BF01806008_CR132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ijc.2910290105","volume":"29","author":"JW Moore","year":"1982","unstructured":"Moore JW, Clark GMG, Bulbrook RD, Hayward JL, Murai JT, Hammond GL, Siiteri PK: Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer 29:17\u201321, 1982","journal-title":"Int J Cancer"},{"key":"BF01806008_CR133","first-page":"153","volume":"112","author":"SW Moore","year":"1961","unstructured":"Moore SW, Pearce J, Ring E: Intraductal papilloma of the breast. Surg Gynecol Obstet 112:153\u2013158, 1961","journal-title":"Surg Gynecol Obstet"},{"key":"BF01806008_CR134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oxfordjournals.aje.a121591","volume":"99","author":"RW Morgan","year":"1974","unstructured":"Morgan RW, Vakil DV, Chipman ML: Breast-feeding, family history and breast disease. Am J Epidemiol 99:117\u2013122, 1974","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR135","first-page":"1124","volume":"20","author":"E Mouravieva","year":"1964","unstructured":"Mouravieva E, Manouylova IA, Smirnova N, Charooukhova K: Les particularites des desquilibres hormonaux dans la mastopathie. Acta Un Int Can 20:1124\u20131125, 1964","journal-title":"Acta Un Int Can"},{"key":"BF01806008_CR136","first-page":"1347","volume":"63","author":"T Nemoto","year":"1979","unstructured":"Nemoto T, Constantine R, Chu TM: Human tissue polypeptide antigen in breast cancer. J Nat Cancer Inst 63: 1347\u20131350, 1979","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR137","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/oxfordjournals.aje.a112245","volume":"103","author":"A Nomura","year":"1976","unstructured":"Nomura A, Comstock GW: Benign breast tumor and estrogenic hormones: A population-based retrospective study. Am J Epidemiol 103:439\u2013444, 1976","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR138","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/oxfordjournals.aje.a112413","volume":"105","author":"A Nomura","year":"1977","unstructured":"Nomura A, Comstock GW, Tonascia JA: Epidemiologic characteristics of benign breast disease. Am J Epidemiol 105:505\u2013512, 1977","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR139","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1507\/endocrine1927.52.5_595","volume":"52","author":"N Ofuji","year":"1976","unstructured":"Ofuji N, Ogawa N, Miyoshi M, Takahara J, Ofuji T, Tanaka S, Itagaki F: Plasma prolactin and thyroid-stimulating hormone in patients with breast cancer. Folia Endocrinol Jap 52:595\u2013571, 1976","journal-title":"Folia Endocrinol Jap"},{"key":"BF01806008_CR140","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/1097-0142(197603)37:3<1412::AID-CNCR2820370323>3.0.CO;2-4","volume":"37","author":"S Ohgo","year":"1976","unstructured":"Ohgo S, Kato Y, Chihara K, Imura H: Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer. Cancer 37:1412\u20131416, 1976","journal-title":"Cancer"},{"key":"BF01806008_CR141","first-page":"17","volume":"70","author":"H Olsson","year":"1983","unstructured":"Olsson H, Landin-Olsson M, Gullberg B: Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease and in women without breast disease. J Nat Cancer Inst 70:17\u201320, 1983","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR142","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9610(79)90094-1","volume":"137","author":"SF Oluwole","year":"1979","unstructured":"Oluwole SF, Freeman HP: Analysis of benign breast lesions in blacks. Am J Surg 137:786\u2013789, 1979","journal-title":"Am J Surg"},{"key":"BF01806008_CR143","first-page":"564","volume":"10","author":"F Opri","year":"1981","unstructured":"Opri F, Kirchner H: Untersuchungen uber das carcinoembryonale Antigen (CEA) und uber die Enzymaktivitaten von alkalischer und saurer Phosphatase beim Mastopathia fibro-cystica. Zbl Gynakol 10:564\u2013568, 1981","journal-title":"Zbl Gynakol"},{"key":"BF01806008_CR144","first-page":"690","volume":"39","author":"F Opri","year":"1979","unstructured":"Opri F, Post G, Kirchner H, Hammerstein J: Bestimmung des HCG in Serum und in Zystenpunkten bei verscheidenen Formen der Mastopathik. Geburtsh und Frauenheilk 39:690\u2013693, 1979","journal-title":"Geburtsh und Frauenheilk"},{"key":"BF01806008_CR145","first-page":"412","volume":"294","author":"H Ory","year":"1976","unstructured":"Ory H, Cole P, Macmahon B, Hoover R: Oral contraceptives and reduced risk of benign breast disease. New Engl J med 294:412\u2013422, 1976","journal-title":"New Engl J med"},{"key":"BF01806008_CR146","first-page":"323","volume":"28","author":"L Ozieblo","year":"1977","unstructured":"Ozieblo L: Serum prolactin levels in healthy women and in patients with functional disorders of the mammary glands. Endokrynol Pol 28:323\u2013330, 1977","journal-title":"Endokrynol Pol"},{"key":"BF01806008_CR147","first-page":"1055","volume":"61","author":"DL Page","year":"1978","unstructured":"Page DL, Vander Zwagg R, Rogers LW, Williams LT, Walker WE, Hartman WM: Relation between component parts of fibrocystic disease and breast cancer. J Nat Cancer Inst 61:1055\u20131063, 1978","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR148","first-page":"349","volume":"19","author":"A Papolczay","year":"1978","unstructured":"Papolczay A, Voros A, Bihari I: Chronic cystic mastopathya: Twenty-five years experience. Acta Chirurgica Acad Scientarum Hungaricae 19:349\u2013356, 1978","journal-title":"Acta Chirurgica Acad Scientarum Hungaricae"},{"key":"BF01806008_CR149","first-page":"5","volume":"71","author":"H Pastides","year":"1983","unstructured":"Pastides H, Kelsey JL, Livolsi VA, Holford TR, Fischer DB, Goldenberg IS: Oral contraceptive use and fibrocystic disease with special reference to its histopathology. J Nat Cancer Inst 71:5\u20139, 1983","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR150","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1016\/S0021-9258(19)43566-7","volume":"248","author":"WH Pearlman","year":"1973","unstructured":"Pearlman WH, Gueriguian JL, Sawyer ME; A specific progesterone-binding component of human breast cyst fluid. J Biol Chem 248:5736\u20135741, 1973","journal-title":"J Biol Chem"},{"key":"BF01806008_CR151","first-page":"19P","volume":"75","author":"WH Pearlman","year":"1977","unstructured":"Pearlman WH, Peng LH, Mazoujian G, Haagensen DE, Wells SA, Kister SJ: A specific progesterone-binding component of human breast cyst fluid: its isolation and characterization. J Endocrinol 75:19P-20P, 1977","journal-title":"J Endocrinol"},{"key":"BF01806008_CR152","first-page":"225","volume":"82","author":"OH Pearson","year":"1969","unstructured":"Pearson OH, Llerena O, Llerena L, Molina A, Butler T: Prolactin-dependent rat mammary cancer: A model for man? Trans Assoc Am Physicians 82:225\u2013237, 1969","journal-title":"Trans Assoc Am Physicians"},{"key":"BF01806008_CR153","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0021-9673(00)89976-8","volume":"158","author":"CD Pfaffenberger","year":"1978","unstructured":"Pfaffenberger CD, Malinak LR, Horning EC: Study of urinary steroid metabolite ratios of women with breast lesions using open-tubular glass capillary columns. J Chromatog 158:313\u2013330, 1978","journal-title":"J Chromatog"},{"key":"BF01806008_CR154","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00000658-196806000-00003","volume":"167","author":"JP Potter","year":"1968","unstructured":"Potter JP, Slimbaugh WP, Woodward SC: Can breast carcinoma be anticipated? A follow-up of benign breast biopsies. Ann Surg 167:829\u2013838, 1968","journal-title":"Ann Surg"},{"key":"BF01806008_CR155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-45-3-429","volume":"45","author":"U Raju","year":"1977","unstructured":"Raju U, Ganguly M, Levitz M: Estriol conjugates in human breast cyst fluid and in serum of premenopausal women. J Clin Endocrinol Metab 45:429\u2013434, 1977","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR156","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0014-2964(79)90074-4","volume":"15","author":"B Ravnihar","year":"1979","unstructured":"Ravnihar B, Seigel DG, Lindtner J: An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. Europ J Cancer 15:395\u2013405, 1979","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR157","first-page":"3940","volume":"43","author":"MJ Reed","year":"1983","unstructured":"Reed MJ, Cheng RW, Noel CT, Dudley HAF, James VHT: Plasma levels of estrone, estrone sulfate and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res 43:3940\u20133943, 1983","journal-title":"Cancer Res"},{"key":"BF01806008_CR158","first-page":"581","volume":"6","author":"PH Rolland","year":"1980","unstructured":"Rolland PH, Martin PM, Bourry M, Rolland AM, Serment H: Human benign breast disease: Relationships between prostaglandin E2, steroid hormones and thermographic effects of the inhibitors of prostaglandin biosynthesis. Adv Prostaglandin Thromboxane Res 6:581\u2013584, 1980","journal-title":"Adv Prostaglandin Thromboxane Res"},{"key":"BF01806008_CR159","first-page":"197","volume":"10","author":"PH Rolland","year":"1981","unstructured":"Rolland PH, Martin PM, Bourry M, Serment H: Prostaglandines et mastopathie benigne. J Gyn Obst Biol Repr 10:197\u2013201, 1981","journal-title":"J Gyn Obst Biol Repr"},{"key":"BF01806008_CR160","first-page":"715","volume":"54","author":"PH Rolland","year":"1979","unstructured":"Rolland PH, Martin PM, Rolland AM, Bourry M, Serment H: Benign breast disease: Studies of prostaglandin E2, steroids and thermographic effects of inhibitors of prostaglandin biosynthesis. Obstet Gynecol 54:715\u2013718, 1979","journal-title":"Obstet Gynecol"},{"key":"BF01806008_CR161","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/1097-0142(197508)36:2<399::AID-CNCR2820360215>3.0.CO;2-J","volume":"36","author":"LI Rose","year":"1975","unstructured":"Rose LI, Underwood RH, Dunning MT, Williams GH, Pinkus GS: Testosterone metabolism in benign and malignant breast lesions. Cancer 36:399\u2013403, 1975","journal-title":"Cancer"},{"key":"BF01806008_CR162","first-page":"3187","volume":"35","author":"PP Rosen","year":"1975","unstructured":"Rosen PP, Menendez-Botet CJ, Nisselbaum JS, Urban JA, Mike V, Fracchia A, Schwartz MK: Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res 35:3187\u20133194, 1975","journal-title":"Cancer Res"},{"key":"BF01806008_CR163","first-page":"624","volume":"i","author":"Royal College of General Practitioners","year":"1977","unstructured":"Royal College of General Practitioners: Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives. Lancet i:624, 1977","journal-title":"Lancet"},{"key":"BF01806008_CR164","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM197303152881104","volume":"288","author":"PE Sartwell","year":"1973","unstructured":"Sartwell PE, Arthes FG, Tonascia JA: Epidemiology of benign breast lesions: Lack of associations with oral contraceptive use. New Engl J Med 288:551\u2013554, 1973","journal-title":"New Engl J Med"},{"key":"BF01806008_CR165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ije\/7.3.217","volume":"7","author":"PE Sartwell","year":"1978","unstructured":"Sartwell PE, Arthes FG, Tonascia JA: Benign and malignant breast tumours: Epidemiological similarities. Int J Epidemiol 7:217\u2013221, 1978","journal-title":"Int J Epidemiol"},{"key":"BF01806008_CR166","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0091-7435(78)90245-1","volume":"7","author":"N Sasano","year":"1978","unstructured":"Sasano N, Tateno H, Stemmermann GN: Volume and hyperplastic lesions of breasts of Japanese women in Hawaii and Japan. Prev Med 7:196\u2013204, 1978","journal-title":"Prev Med"},{"key":"BF01806008_CR167","first-page":"1","volume":"54","author":"F Sasse","year":"1897","unstructured":"Sasse F: Uber Cysten und cystische Turnoven der Mamma. Arch Klin Chir 54:1\u201354, 1897","journal-title":"Arch Klin Chir"},{"key":"BF01806008_CR168","first-page":"117","volume":"44","author":"C Schimmelbusch","year":"1892","unstructured":"Schimmelbusch C: Das Cystadenom der Mamma. Arch Klin Chir 44:117\u2013134, 1892","journal-title":"Arch Klin Chir"},{"key":"BF01806008_CR169","first-page":"207","volume":"61","author":"K Schubert","year":"1960","unstructured":"Schubert K, Bacigalupo G: Steroidstoffwechsel bei Mastapathie unter Ostradioleinwirkung. Arch Geschwulstforsch 61:207\u2013217, 1960","journal-title":"Arch Geschwulstforsch"},{"key":"BF01806008_CR170","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/1097-0142(19821101)50:9<1899::AID-CNCR2820500942>3.0.CO;2-A","volume":"50","author":"C Schuerch","year":"1982","unstructured":"Schuerch C, Rosen PP, Hirota T, Itabashi M, Yamamoto H, Kinne DW, Beattie EJ: A pathologic study of benign breast diseases in Tokyo and New York. Cancer 50:1899\u20131903, 1982","journal-title":"Cancer"},{"key":"BF01806008_CR171","first-page":"1213","volume":"22","author":"MK Schwartz","year":"1976","unstructured":"Schwartz MK, Fleisher M, Breed C, Ashikari R, DePalo A, Kinne D, Urban J: Enzyme composition of human breast cyst fluid. Clin Chem 22:1213, 1976","journal-title":"Clin Chem"},{"key":"BF01806008_CR172","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0277-5379(83)90389-9","volume":"19","author":"G Secreto","year":"1983","unstructured":"Secreto G, Fariselli G, Bandieramonte G, Recchione C, Dati V, DiPietro S: Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast. Europ J Cancer Clin Oncol 19:5\u201310, 1983","journal-title":"Europ J Cancer Clin Oncol"},{"key":"BF01806008_CR173","first-page":"1","volume":"10","author":"C Semb","year":"1928","unstructured":"Semb C: Pathologico-anatomical and clinical investigations of fibroadenomatosis cystea mammae and its relationship to other pathological conditions. Acta Chir Scandinavia 64 Suppl 10:1\u2013484, 1928","journal-title":"Acta Chir Scandinavia 64 Suppl"},{"key":"BF01806008_CR174","first-page":"399","volume":"14","author":"MD Serban","year":"1963","unstructured":"Serban MD, Stroe E, Klepsch I, Busila E, Garoiu M: Data hormonale in mastopatii. Studii cercetari endocr 14:399\u2013408, 1963","journal-title":"Studii cercetari endocr"},{"key":"BF01806008_CR175","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/1097-0142(197405)33:5<1306::AID-CNCR2820330515>3.0.CO;2-#","volume":"33","author":"BM Sherman","year":"1974","unstructured":"Sherman BM, Korenman SG: Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemiology. Cancer 33:1306\u20131312, 1974","journal-title":"Cancer"},{"key":"BF01806008_CR176","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/bjc.1975.145","volume":"32","author":"NA Sheth","year":"1975","unstructured":"Sheth NA, Ranadive KJ, Suraiya JN, Sheth AR: Circulating levels of prolactin in human breast cancer. Brit J Cancer 32:160\u2013167, 1975","journal-title":"Brit J Cancer"},{"key":"BF01806008_CR177","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2559.1978.tb01737.x","volume":"2","author":"S Shousha","year":"1978","unstructured":"Shousha S, Lyssiotis T: Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma. Histopathol 2:433\u2013447, 1978","journal-title":"Histopathol"},{"key":"BF01806008_CR178","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(197203)29:3<574::AID-CNCR2820290307>3.0.CO;2-B","volume":"29","author":"SG Silverberg","year":"1972","unstructured":"Silverberg SG, Chitale AR, Levitt SH: Prognostic implications of fibrocystic dysplasia in breasts removed for mammary carcinoma. Cancer 29:574\u2013580, 1972","journal-title":"Cancer"},{"key":"BF01806008_CR179","unstructured":"Simkin B: Elevated serum prolactin in women with benign and malignant breast disease. 64th Annual meeting of the U.S. Endocrine Society, p 443, 1982"},{"key":"BF01806008_CR180","first-page":"131","volume-title":"Estrogen Receptors in Human Breast Cancer","author":"A Singhakowinta","year":"1975","unstructured":"Singhakowinta A, Mohindra R, Brooks SC, Vaitkevicius VK, Brennan MJ: Clinical correlation of endocrine therapy and estrogen receptor.In McGuire WH, Carbone PP, Vollmer EP (eds): Estrogen Receptors in Human Breast Cancer. Raven Press, New York, pp. 131\u2013148, 1975"},{"key":"BF01806008_CR181","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jcem-44-4-771","volume":"44","author":"LR Sitruk-Ware","year":"1977","unstructured":"Sitruk-Ware LR, Sterkers N, Mowszowicz I, Mauvais-Jarvis P: Inadequate corpus luteum function in women with benign breast disease. J Clin Endocrinol Metab 44:771\u2013774, 1977","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806008_CR182","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.aje.a113216","volume":"114","author":"I Soini","year":"1981","unstructured":"Soini I, Aine R, Lauslahti K, Hakama M: Independent risk factors of benign and malignant breast lesions. Am J Epidemiol 114:507\u2013514, 1981","journal-title":"Am J Epidemiol"},{"key":"BF01806008_CR183","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/BF01934057","volume":"33","author":"LS Srivastava","year":"1977","unstructured":"Srivastava LS, Pescovitz H, Singh RD, Perisutti G, Knowles HC: Radioimmunoassay of some hormones simultaneously measured in serum and breast cyst fluid. Experientia 33:1659\u20131660, 1977","journal-title":"Experientia"},{"key":"BF01806008_CR184","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O","volume":"33","author":"AM Steward","year":"1974","unstructured":"Steward AM, Nixon D, Zamcheck N, Aisenberg A: Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress. Cancer 33:1246\u20131252, 1974","journal-title":"Cancer"},{"key":"BF01806008_CR185","first-page":"3814","volume":"41","author":"GS Sundaram","year":"1981","unstructured":"Sundaram GS, London R, Margolis S, Wenk R, Lustgarten J, Nair PP, Goldstein P: Serum hormones and lipoproteins in benign breast disease. Cancer Res 41: 3814\u20133816, 1981","journal-title":"Cancer Res"},{"key":"BF01806008_CR186","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0014-2964(73)90144-8","volume":"9","author":"MC Swain","year":"1973","unstructured":"Swain MC, Hayward JL, Bulbrook RD: Plasma oestradiol and progesterone in benign breast disease. Europ J Cancer 9:553\u2013556, 1973","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR187","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ijc.2910220608","volume":"22","author":"A Tarquini","year":"1978","unstructured":"Tarquini A, Di Martino L, Malloci A, Kwa HG, Van Der Gugten AA, Bulbrook RD, Wang DY: Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease. Int J Cancer 22:687\u2013690, 1978","journal-title":"Int J Cancer"},{"key":"BF01806008_CR188","first-page":"101","volume":"7","author":"B Tarquini","year":"1980","unstructured":"Tarquini B, Gheri R, Romano S, Costa A, Cagnoni M, Lee JK, Halberg F: Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy. Int J Chronobiology 7:101\u2013115, 1980","journal-title":"Int J Chronobiology"},{"key":"BF01806008_CR189","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcp.1041020306","volume":"102","author":"J Taylor-Papadimitriou","year":"1980","unstructured":"Taylor-Papadimitriou J, Purkis P, Fentiman IS: Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells. J Cell Physiol 102:317\u2013321, 1980","journal-title":"J Cell Physiol"},{"key":"BF01806008_CR190","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/1097-0142(197405)33:5<1364::AID-CNCR2820330522>3.0.CO;2-7","volume":"33","author":"L Terenius","year":"1974","unstructured":"Terenius L, Johansson H, Rimsten A, Thoren L: Malignant and benign human mammary disease: Estrogen binding in relation to clinical data. Cancer 33:1364\u20131368, 1974","journal-title":"Cancer"},{"key":"BF01806008_CR191","first-page":"3991","volume":"38","author":"DB Thomas","year":"1978","unstructured":"Thomas DB: Role of exogenous female hormones in altering the risk of benign and malignant neoplasms in humans. Cancer Res 38:3991\u20134000, 1978","journal-title":"Cancer Res"},{"key":"BF01806008_CR192","first-page":"1017","volume":"69","author":"DB Thomas","year":"1982","unstructured":"Thomas DB, Persing JP, Hutchinson WB: Exogenous estrogens and other risk factors for breast cancer in women with benign breast disease. J Nat Cancer Inst 69:1017\u20131025, 1982","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR193","first-page":"317","volume":"6","author":"GSJ Thynne","year":"1980","unstructured":"Thynne GSJ, Greening WP: A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast. Clin Oncol 6:317\u2013321, 1980","journal-title":"Clin Oncol"},{"key":"BF01806008_CR194","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.1977.tb29416.x","volume":"286","author":"L Tseng","year":"1977","unstructured":"Tseng L, Gusberg SB, Gurpide E: Estradiol receptor and 17\u03b2-dehydrogenase in normal and abnormal human endometrium. Ann NY Acad Sci 286:190\u2013198, 1977","journal-title":"Ann NY Acad Sci"},{"key":"BF01806008_CR195","first-page":"329","volume":"4","author":"LN Varnavides","year":"1978","unstructured":"Varnavides LN, O'Higgins NJ, Clark CG: Carcinoembryonic antigen (CEA) in mammary disease: a clinical evaluation. Clin Oncol 4:329\u2013337, 1978","journal-title":"Clin Oncol"},{"key":"BF01806008_CR196","first-page":"529","volume":"126","author":"V Veronesi","year":"1968","unstructured":"Veronesi V, Pizzocaro G: Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet 126:529\u2013532, 1968","journal-title":"Surg Gynecol Obstet"},{"key":"BF01806008_CR197","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/bmj.3.5829.719","volume":"3","author":"MP Vessey","year":"1972","unstructured":"Vessey MP, Doll R, Sutton PM: Oral contraceptives and breast neoplasia: A retrospective study. Brit Med J 3:719\u2013724, 1972","journal-title":"Brit Med J"},{"key":"BF01806008_CR198","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0277-5379(84)90051-8","volume":"20","author":"PV Walsh","year":"1984","unstructured":"Walsh PV, Wang DY, McDicken I, Stell PM, Bulbrook RD, George D: Serum progesterone concentration during the luteal phase in women with benign breast disease. Europ J Cancer Clin Oncol 20:1339\u20131343, 1984","journal-title":"Europ J Cancer Clin Oncol"},{"key":"BF01806008_CR199","first-page":"30","volume-title":"Hormonal Management of Endocrine-Related Cancer","author":"DY Wang","year":"1981","unstructured":"Wang DY: Secretion and metabolism of hormones by tumours.In Stoll BA (ed): Hormonal Management of Endocrine-Related Cancer. Lloyd-Luke Ltd, London, pp 30\u201340, 1981"},{"key":"BF01806008_CR200","first-page":"68","volume-title":"Endocrine Relationships in Breast Cancer","author":"DY Wang","year":"1982","unstructured":"Wang DY: Steroid metabolism and ectopic hormone production in breast cancer.In Stoll BA (ed): Endocrine Relationships in Breast Cancer. Heinemann, London, pp 68\u201384, 1982"},{"key":"BF01806008_CR201","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2964(66)90051-X","volume":"2","author":"DY Wang","year":"1966","unstructured":"Wang DY, Hayward JL, Bulbrook RD: Testosterone levels in the plasma of normal women and patients with benign breast disease or breast cancer. Europ J Cancer 2:373\u2013376, 1966","journal-title":"Europ J Cancer"},{"key":"BF01806008_CR202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4684-2301-3_11","volume-title":"Principles of Surgical Oncology","author":"DY Wang","year":"1977","unstructured":"Wang DY, Bulbrook RD: Hormones and neoplasia.In Raven RW (ed): Principles of Surgical Oncology. Plenum, New York, pp. 227\u2013261, 1977"},{"key":"BF01806008_CR203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0277-5379(84)90030-0","volume":"20","author":"DY Wang","year":"1984","unstructured":"Wang DY, Knyba RE, Bulbrook RD, Millis RR, Hayward JL: Serum carcinoembryonic antigen in diagnosis and prognosis of women with breast cancer. Europ J Cancer Clin Oncol 20:25\u201331, 1984","journal-title":"Europ J Cancer Clin Oncol"},{"key":"BF01806008_CR204","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.2910330513","volume":"33","author":"DY Wang","year":"1984","unstructured":"Wang DY, Sturzaker HE, Kwa HG, Verhofstad F, Hayward JL, Bulbrook RD: Nycthemeral changes in plasma prolactin levels and its relationship to breast cancer risk. Int J Cancer 33:629\u2013632, 1984","journal-title":"Int J Cancer"},{"key":"BF01806008_CR205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.1905.52510030006002","volume":"45","author":"JC Warren","year":"1905","unstructured":"Warren JC: The surgeon and the pathologist. A plea for reciprocity as illustrated by the considerations of the classification and treatment of benign tumours of the breast. JAMA 45:149\u2013165, 1905","journal-title":"JAMA"},{"key":"BF01806008_CR206","first-page":"252","volume":"29","author":"S Watt-Boolsen","year":"1982","unstructured":"Watt-Boolsen S, Emus HC, Junge J: Fibrocystic disease and mastalgia: A histological and enzyme-histochemical study. Danish Med Bull 29:252\u2013254, 1982","journal-title":"Danish Med Bull"},{"key":"BF01806008_CR207","first-page":"231","volume":"55","author":"SR Wellings","year":"1975","unstructured":"Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Nat Cancer Inst 55:231\u2013273, 1975","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR208","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ajcp\/73.5.669","volume":"73","author":"EJ Wilkinson","year":"1980","unstructured":"Wilkinson EJ, Hause LL, Sasse EA, Pattillo RA, Millbrath JR, Lewis JD: Carcinoembryonic antigen and L-fucose in malignant and benign mammary disease. Am J Clin Path 73:669\u2013675, 1980","journal-title":"Am J Clin Path"},{"key":"BF01806008_CR209","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0090-1229(82)90120-9","volume":"23","author":"SS Witkin","year":"1982","unstructured":"Witkin SS, Richards JM, Bongiovanni AM, Breed CN, Day NK: Sera from breast cancer patients contain an IgA antibody to a breast cyst fluid component. Clin Immunol Immunopath 23:358\u2013365, 1982","journal-title":"Clin Immunol Immunopath"},{"key":"BF01806008_CR210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1172\/JCI110016","volume":"67","author":"SS Witkin","year":"1981","unstructured":"Witkin SS, Sarkar NH, Kinne DW, Breed CN, Good RA, Day NK: Antigens and antibodies cross-reactive to the murine mammary tumour virus in human breast cyst fluids. J Clin Invest 67:216\u2013222, 1981","journal-title":"J Clin Invest"},{"key":"BF01806008_CR211","first-page":"381","volume":"2","author":"C Wittekind","year":"1981","unstructured":"Wittekind C, Von Kleist S, Sandritter W: CEA positivity in tissue and sera of patients with benign breast lesions. Oncodev Biol Med 2:381\u2013390, 1981","journal-title":"Oncodev Biol Med"},{"key":"BF01806008_CR212","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-2008-1037332","volume":"40","author":"K Wurster","year":"1980","unstructured":"Wurster K, Heberling D, Rapp W: CEA und Laktoferrin bei gutartigen und bosartigen Erkrankungen der Mamma. Geburtsh Frauenheilk 40:412\u2013422, 1980","journal-title":"Geburtsh Frauenheilk"},{"key":"BF01806008_CR213","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 312:146\u2013151, 1985","journal-title":"New Engl J Med"},{"key":"BF01806008_CR214","first-page":"1015","volume":"72","author":"CA Boyle","year":"1984","unstructured":"Boyle CA, Berkowitz GS, LiVolsi VA, Ort S, Merino MJ, White C, Kelsey JL: Caffeine consumption and fibrocystic disease: A case-control epidemiological study. J Nat Cancer Inst 72:1015\u20131019, 1984","journal-title":"J Nat Cancer Inst"},{"key":"BF01806008_CR215","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/1097-0142(19840315)53:6<1311::AID-CNCR2820530615>3.0.CO;2-R","volume":"53","author":"S Kumar","year":"1984","unstructured":"Kumar S, Mansel RE, Hughes LE, Woodhead JS, Edwards CA, Scanlon MF, Newcombe RG: Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 53:1311\u20131315, 1984","journal-title":"Cancer"},{"key":"BF01806008_CR216","first-page":"381","volume":"64","author":"F Peters","year":"1984","unstructured":"Peters F, Schuth W, Scheurich B, Breckwoldt M: Serum prolactin levels in patients with fibrocystic breast disease. Obstet Gynecol 64:381\u2013385, 1984","journal-title":"Obstet Gynecol"},{"key":"BF01806008_CR217","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0022-4731(84)90298-X","volume":"21","author":"E Luchene Van","year":"1984","unstructured":"Van Luchene E, Van de Kerckhove D, De Boever J, Sandra P: Structures and concentrations of fifteen different steroid sulfates in human breast cyst fluid. J Steroid Biochem 21:367\u2013371, 1984.","journal-title":"J Steroid Biochem"},{"key":"BF01806008_CR218","first-page":"35","volume":"10","author":"PL Yap","year":"1984","unstructured":"Yap PL, Miller WR, Roberts MM, Creel RJ, Freedman B, Mirtle CL, Pryde EAD, McClelland DBL: Protein concentrations in fluid from gross cystic disease of the breast. Clin Oncol 10:35\u201343, 1984","journal-title":"Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806008\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T12:34:22Z","timestamp":1626093262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,2]]},"references-count":218,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,2]]}},"alternative-id":["BF01806008"],"URL":"https:\/\/doi.org\/10.1007\/bf01806008","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,2]]}}}